Wedbush Securities Inc. cut its holdings in shares of Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Rating) by 4.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,270 shares of the company’s stock after selling 612 shares during the quarter. Wedbush Securities Inc. owned about 0.36% of Innovator IBD 50 ETF worth $268,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. IHT Wealth Management LLC lifted its position in Innovator IBD 50 ETF by 6.5% during the first quarter. IHT Wealth Management LLC now owns 11,193 shares of the company’s stock worth $438,000 after acquiring an additional 685 shares during the last quarter. Affiance Financial LLC bought a new position in shares of Innovator IBD 50 ETF during the fourth quarter worth approximately $34,000. National Bank of Canada FI lifted its holdings in Innovator IBD 50 ETF by 5.4% during the 4th quarter. National Bank of Canada FI now owns 31,074 shares of the company’s stock worth $675,000 after purchasing an additional 1,595 shares during the last quarter. Financial Enhancement Group LLC boosted its stake in Innovator IBD 50 ETF by 18.5% in the 3rd quarter. Financial Enhancement Group LLC now owns 11,462 shares of the company’s stock valued at $280,000 after purchasing an additional 1,793 shares during the period. Finally, UBS Group AG grew its holdings in Innovator IBD 50 ETF by 6.8% in the 1st quarter. UBS Group AG now owns 36,561 shares of the company’s stock valued at $1,429,000 after buying an additional 2,328 shares in the last quarter.
Innovator IBD 50 ETF Price Performance
FFTY stock opened at $24.33 on Wednesday. Innovator IBD 50 ETF has a fifty-two week low of $21.43 and a fifty-two week high of $36.97. The stock has a market capitalization of $82.72 million, a price-to-earnings ratio of 10.61 and a beta of 1.14. The business’s fifty day moving average price is $23.18 and its two-hundred day moving average price is $23.77.
Innovator IBD 50 ETF Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Further Reading
- Get a free copy of the StockNews.com research report on Innovator IBD 50 ETF (FFTY)
- Gamida Cell Stock Jumps Over 100% on FDA Approval
- Insiders Buy EasyJet, Regularly And Repeatedly
- Bank of America Beats Earnings, Renews Investor Upside Potential
- The Analysts See A Bright Future For Sunrun
- J.B. Hunt: Economic Contraction And A Buying Opportunity
Want to see what other hedge funds are holding FFTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Rating).
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
